The Hospital Universitario 12 de Octubre is a public general hospital in the neighborhood of Orcasur, in Madrid, Spain. It is part of the hospital network of the Servicio Madrileño de Salud.

There are 1,256 beds in Hospital Universitario 12 de Octubre.

During the past decade, Hospital Universitario 12 de Octubre conducted 950 clinical trials. In the 10-year time frame, 950 clinical trials started and 264 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 515 clinical trials started and 179 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario 12 de Octubre" #1 sponsor was "PETHEMA Foundation" with 60 trials, followed by "Pfizer" with 58 trials sponsored, "Janssen Research & Development, LLC" with 57 trials sponsored, "Celgene" with 48 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 48 trials sponsored. Other sponsors include 1034 different institutions and companies that sponsored additional 464 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario 12 de Octubre" #1 collaborator was "Bristol-Myers Squibb" with 24 trials as a collaborator, "Merck Sharp & Dohme LLC" with 24 trials as a collaborator, "Pfizer" with 24 trials as a collaborator, "AstraZeneca" with 21 trials as a collaborator and "Hospital Universitario 12 de Octubre" with 21 trials as a collaborator. Other collaborators include 890 different institutions and companies that were collaborators in the rest 559 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario 12 de Octubre" are "Multiple Myeloma" (52 trials), "Breast Cancer" (45 trials), "Pulmonary Arterial Hypertension" (21 trials), "Acute Myeloid Leukemia" (18 trials) and "Carcinoma, Non-Small-Cell Lung" (18 trials). Many other conditions were trialed in "Hospital Universitario 12 de Octubre" in a lesser frequency.

Most popular intervention types in "Hospital Universitario 12 de Octubre" are "Drug" (997 trials), "Other" (120 trials), "Biological" (92 trials), "Device" (64 trials) and "Procedure" (58 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (174 trials), "Dexamethasone" (42 trials), "Carboplatin" (36 trials), "Gemcitabine" (30 trials) and "Cisplatin" (27 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario 12 de Octubre" are 1168 trials for "All" genders, 85 trials for "Female" genders and 50 trials for "Male" genders.

Currently, there are 525 active trials in "Hospital Universitario 12 de Octubre". 6 are not yet recruiting, 303 are recruiting, 212 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 569 completed trials in Hospital Universitario 12 de Octubre, 1 suspended trials, and 122 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario 12 de Octubre, 173 "Phase 1" clinical trials were conducted, 479 "Phase 2" clinical trials and 418 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 65 trials, and there were also 72 trials that are defined as “Not Applicable".

Hospital Universitario 12 de Octubre has several departments that took part in Clinical trials: "Hospital Univ. 12 de Octubre; Servicio de Hematologia" - 13 trials, "Hospital Universitario 12 de Octubre; Servicio de Neurologia" - 12 trials, "Unidad de Enfermedades Infecciosas. Hospital Universitario 12 de Octubre" - 4 trials, "Hospital Universitario 12 de Octubre, Nephrology Department" - 4 trials, "Hospital Universitario 12 de Octubre; Servicio de Reumatologia" - 3 trials, "Hospital Universitario 12 de Octubre; Servicio de Pediatria" - 3 trials, "Hospital Universitario 12 de Octubre; Servicio de Neumologia" - 2 trials